NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/02/2026
Back to search
Official data from USPTO
STABOLY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
06/02/2026
Trademark type
Word
Nice classes
1, 5
Filing date
06/26/2024
Registration date
06/02/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/02/2026
Last transaction
06/02/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/30/2025
First use in commerce
10/30/2025
Drawing code
4
Owner type
03
Owner location
Staad, CH
Examiner
ZAVALA DIEK, JOSEPH MARCO
Law office
M80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Biosynth AG
Representatives
Tara Reedy Sliva Dentons US LLP
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Biochemicals and organic chemicals used as enzyme substratesenzyme inducersaminoglutethimidescarbamazepinesgriseofulvinsprimidonesenzyme inactivatorscultural medium additives for scientific and research use in the field of microbiology and molecular biology; biochemical and organic chemicals for use in the manufacture of pharmaceuticals and cosmetics; Chemical reagents for medical research use in the field of immunology; Chemical reagents for medical laboratory analysis research purposesfor use as a routine medical supplement to blood culture media in vitro to inhibit blood coagulation and to improve the detection limits for individual microorganisms
Class 5
Medicinal preparationsphotosensitizing agents used as a dermatologic drug for the treatment of skin cancer by phototherapy; Chemical reagents for medical or veterinarian use; Chemical reagents for use as culture media for cultures of microorganisms for medical usefor the isolation and identification of the bacteria strain Escherichia coli O157:H7; Chemical preparations for medical purposesfor Cholesterol testing to prevent possible consequences of Hypercholesterolemia such as atherosclerosiscoronary heart disease and other forms of cardiovascular diseases; Chemical preparations for medical purposesfor novel enzyme responsive inhibitors that allow for modifications of the composition of microbial communitiesfor medical treatment purpose and diagnostic use; Organic chemical preparations for medical purposesimmunomodulators with anti-inflammatory properties for treating blood disordersautoimmune diseasesallergic conditions; Organic chemical preparations and enzymes for medical laboratory diagnostic analysis purposesfor medical detectionidentification and quantification of strains of pathogenic bacteria; Chemical preparations for medical laboratory diagnostic analysis purposesfor medical immunological and microbiological blood testing; Chemical preparations for medical laboratory analysis purposesfor medical detection of pathogenic bacteriavarious strains of ListeriaClostridiumBacillus and Staphylococcus; Chemical preparations for medical laboratory analysis purposesfor the medical detection and quantification of bacteria strains of Escherichia coli; Medical preparations for the diagnosis of Staphylococcus aureusin particular for Methicillin-resistant Staphylococcus aureus (MRSA); biochemical and organic chemical reagents for clinical diagnostic laboratory use
Publications
History of USPTO decisions and trademark events.
29 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/02/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/11/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/11/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/04/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/04/2026
ALIE
ASSIGNED TO LIE
05/04/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/30/2026
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/13/2026
GNRT
NON-FINAL ACTION E-MAILED
04/13/2026
CNRT
SU - NON-FINAL ACTION - WRITTEN
04/13/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/11/2026
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/11/2026
IUAF
USE AMENDMENT FILED
10/31/2025
EISU
TEAS STATEMENT OF USE RECEIVED
10/31/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/27/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/01/2025
PUBO
PUBLISHED FOR OPPOSITION
04/01/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/26/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/06/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/13/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/13/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/13/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/22/2025
GNRT
NON-FINAL ACTION E-MAILED
01/22/2025
CNRT
NON-FINAL ACTION WRITTEN
01/22/2025
DOCK
ASSIGNED TO EXAMINER
01/21/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/19/2025
NWAP
NEW APPLICATION ENTERED
06/26/2024
Continuous trademark protection
Get notified about every new filing that threatens STABOLY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.